AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 81 filers reported holding AVROBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $226,996 | +125.4% | 147,400 | +39.1% | 0.01% | +200.0% |
Q2 2023 | $100,711 | -5.0% | 106,000 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $106,000 | -4.7% | 106,000 | -32.1% | 0.00% | 0.0% |
Q4 2022 | $111,212 | +11.2% | 156,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $100,000 | -19.4% | 156,000 | +15.6% | 0.00% | 0.0% |
Q2 2022 | $124,000 | -59.7% | 135,000 | -42.1% | 0.00% | -50.0% |
Q1 2022 | $308,000 | -47.7% | 233,100 | +52.3% | 0.01% | -45.5% |
Q4 2021 | $589,000 | – | 153,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |